LIGNAPHARMA
0840.469.861 · rovalta.com · 08/11/2026
ACTIVE
LIGNAPHARMA
Financial year 2025 · Closed on 30/06/2025
Net result62,7 k €-14,1 %over 1 year
Gross margin109 k €-16,3 %over 1 year
Equity36,3 k €0,0 %over 1 year
Overview
Identity
Source · BCE/KBOLIGNAPHARMA is a Private limited company incorporated in 2011. Its main activity is: Agents involved in the sale of food, beverages and tobacco. Its registered office is in Mol.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0840.469.861
- Incorporation
- 19/10/2011
- Legal form
- Private limited company
- Registered office
- Gompelbaan 114
2400 Mol · FlandreSee on map - Contributed capital
- 33 000,00 €
- Latest accounts
- 30/06/2025
Activities (NACE)
46170Agents involved in the sale of food, beverages and tobacco· main46170Agents involved in the sale of food, beverages and tobacco46389Wholesale of other food, including fish, crustaceans and molluscs10860Manufacture of homogenised food preparations and dietetic food10860Manufacture of homogenised food preparations and dietetic food21201Manufacture of pharmaceutical preparations+5
Signals
ProfitablePositive cashflowPositive EBITDA
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 109 k € | -16.3% | 130,2 k € | -9.3% | 143,5 k € | +14.3% | 125,5 k € | -24.4% | 166,2 k € |
| EBITDA | 104,7 k € | -15.7% | 124,2 k € | -10.7% | 139,1 k € | +12.0% | 124,2 k € | -23.0% | 161,4 k € |
| Operating result | 89,1 k € | -18.9% | 109,9 k € | -4.2% | 114,7 k € | +33.6% | 85,8 k € | -40.9% | 145,3 k € |
| Net result | 62,7 k € | -14.1% | 73 k € | -10.5% | 81,6 k € | +29.6% | 62,9 k € | -40.9% | 106,5 k € |
| Balance sheet | |||||||||
| Equity | 36,3 k € | 0.0% | 36,3 k € | 0.0% | 36,3 k € | 0.0% | 36,3 k € | 0.0% | 36,3 k € |
| Total assets | 249,9 k € | -0.2% | 250,5 k € | +38.3% | 181,1 k € | -22.8% | 234,7 k € | -24.8% | 312,2 k € |
| Cash | 121,7 k € | +31.6% | 92,5 k € | +80.5% | 51,2 k € | -49.7% | 101,9 k € | -42.2% | 176,2 k € |
| Debts | 196,6 k € | -0.2% | 197 k € | +51.5% | 130 k € | -28.0% | 180,5 k € | -34.6% | 275,9 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20251 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/01/2017 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Mary Romano | Manager19/10/2011 → 31/12/2016Director2024 accounts | ||
Dirk Janssen | Manager2013 accounts |
Other companies at this address
Gompelbaan 114 2400 Mol| Company | CBE no. |
|---|---|
IMMO UMBRIA● Active | 0668.425.812 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/12/2025 | 16/12/2024 | 21/12/2023 | 21/12/2022 | 23/12/2021 | 25/01/2021 |
| General meeting | 11/12/2025 | 12/12/2024 | 14/12/2023 | 08/12/2022 | 22/12/2021 | 10/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 11/12/2025 | 17/12/2025 | Dutch | |
| Micro model | 30/06/2024 | 12/12/2024 | 16/12/2024 | Dutch | |
| Micro model | 30/06/2023 | 14/12/2023 | 21/12/2023 | Dutch | |
| Micro model | 30/06/2022 | 08/12/2022 | 21/12/2022 | Dutch | |
| Abridged model | 30/06/2021 | 22/12/2021 | 23/12/2021 | Dutch | |
| Abridged model | 30/06/2020 | 10/12/2020 | 25/01/2021 | Dutch | |
| Abridged model | 30/06/2019 | 12/12/2019 | 14/02/2020 | Dutch | |
| Abridged model | 30/06/2018 | 13/12/2018 | 14/01/2019 | Dutch | |
| Abridged model | 30/06/2017 | 14/12/2017 | 23/02/2018 | Dutch | |
| Abridged model | 30/06/2016 | 08/12/2016 | 21/12/2016 | Dutch | |
| Abridged model | 30/06/2015 | 10/12/2015 | 04/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 11/12/2014 | 16/12/2014 | Dutch | |
| Abridged model | 30/06/2013 | 12/12/2013 | 23/01/2014 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/01/2017 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Mary Romano | Manager19/10/2011 → 31/12/2016Director2024 accounts | ||
Dirk Janssen | Manager2013 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings13 filings
Mandates
IMMO UMBRIA
Mary Romano
Mary Romary
Dirk Janssen
2011201220132014201520162017201820192020202120222023202420252026
LIGNAPHARMA
Gompelbaan 114, 2400 Mol
Director
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Gompelbaan 114, 2400 MolCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00591479 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| LIGNAPHARMACurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00591479 |
Events
- 2025Annual accounts 202562,7 k €↓
- 2024Annual accounts 202473 k €↓
- 2023Annual accounts 202381,6 k €↑
- 2022Annual accounts 202262,9 k €↓
- 2021Annual accounts 2021106,5 k €↑
- 2020Annual accounts 202071,7 k €↑
- 2019Annual accounts 201929,3 k €↓
- 2018Annual accounts 201832,4 k €↓
- 2017Annual accounts 201790 k €↓
- 2016Annual accounts 2016110 k €↑
- 2015Annual accounts 201586,5 k €↓
- 2014Annual accounts 201491,7 k €↓
- 2013Annual accounts 2013128,7 k €
- 19/10/2011IncorporationPrivate limited company